Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis
Clinical trial NCT01382654 · COMPLETED
Trial details
- NCT number
- NCT01382654
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2006-10-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.